Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mol Microbiol ; 116(4): 1022-1032, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-34342063

RESUMEN

Biosynthesis and secretion of a complex extracellular matrix (EM) is a hallmark of Salmonella biofilm formation, impacting on its relationship with both the environment and the host. Cellulose is a major component of Salmonella EM. It is considered an anti-virulence factor because it interferes with Salmonella proliferation inside macrophages and virulence in mice. Its synthesis is stimulated by CsgD, the master regulator of biofilm formation in enterobacteria, which in turn is under the control of MlrA, a MerR-like transcription factor. In this work, we identified a SPI-2-encoded Salmonella-specific transcription factor homolog to MlrA, MlrB, that represses transcription of its downstream gene, orf319, and of csgD inside host cells. MlrB is induced in laboratory media mimicking intracellular conditions and inside macrophages, and it is required for intramacrophage proliferation. An increased csgD expression is observed in the absence of MlrB inside host cells. Interestingly, inactivation of the CsgD-controlled cellulose synthase-coding gene restored intramacrophage proliferation to rates comparable to wild-type bacteria in the absence of MlrB. These data indicate that MlrB represses CsgD expression inside host cells and suggest that this repression lowers the activation of the cellulose synthase. Our findings provide a novel link between biofilm formation and Salmonella virulence.


Asunto(s)
Proteínas Bacterianas/metabolismo , Celulosa/metabolismo , Matriz Extracelular/metabolismo , Proteínas de la Membrana/metabolismo , Salmonella typhimurium/genética , Salmonella typhimurium/metabolismo , Transactivadores/metabolismo , Animales , Proteínas Bacterianas/genética , Biopelículas , Regulación Bacteriana de la Expresión Génica , Interacciones Microbiota-Huesped , Macrófagos/microbiología , Proteínas de la Membrana/genética , Ratones , Células RAW 264.7 , Infecciones por Salmonella/microbiología , Salmonella typhimurium/patogenicidad , Transactivadores/genética , Transcripción Genética , Virulencia , Factores de Virulencia/metabolismo
2.
Artículo en Inglés | MEDLINE | ID: mdl-29038264

RESUMEN

Carbapenem-resistant Enterobacteriaceae (CRE) are rapidly spreading and taking a staggering toll on all health care systems, largely due to the dissemination of genes coding for potent carbapenemases. An important family of carbapenemases are the Zn(II)-dependent ß-lactamases, known as metallo-ß-lactamases (MBLs). Among them, the New Delhi metallo-ß-lactamase (NDM) has experienced the fastest and widest geographical spread. While other clinically important MBLs are soluble periplasmic enzymes, NDMs are lipoproteins anchored to the outer membrane in Gram-negative bacteria. This unique cellular localization endows NDMs with enhanced stability upon the Zn(II) starvation elicited by the immune system response at the sites of infection. Since the first report of NDM-1, new allelic variants (16 in total) have been identified in clinical isolates differing by a limited number of substitutions. Here, we show that these variants have evolved by accumulating mutations that enhance their stability or the Zn(II) binding affinity in vivo, overriding the most common evolutionary pressure acting on catalytic efficiency. We identified the ubiquitous substitution M154L as responsible for improving the Zn(II) binding capabilities of the NDM variants. These results also reveal that Zn(II) deprivation imposes a strict constraint on the evolution of this MBL, overriding the most common pressures acting on catalytic performance, and shed light on possible inhibitory strategies.


Asunto(s)
Farmacorresistencia Bacteriana Múltiple/genética , Zinc/metabolismo , beta-Lactamasas/genética , Antibacterianos/farmacología , Proteínas Bacterianas/genética , Carbapenémicos/farmacología , Enterobacteriaceae/efectos de los fármacos , Enterobacteriaceae/genética , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Humanos , Pruebas de Sensibilidad Microbiana/métodos , beta-Lactamasas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA